October 9 - 12, 2012
Building 10 & Natcher Conference Center
- General Schedule of Events
- Opening Plenary Session
- Concurrent Symposia Sessions
- National Graduate Student Research Conference
- FARE Award Ceremony
- Poster Sessions
- Special Exhibits on Resources for Intramural Research
- TSA Research Festival Exhibit Show
- Research Festival Committees
- Past Research Festivals
2011 program
Download the 2011 Research Festival Program Book
PDF documents require the free Adobe Reader
Muc5ac is required for IL-4 and IL-13-mediated signaling through the type II IL-4 receptor complex
| Thursday, October 11, 2012 — Poster Session IV | |||
|---|---|---|---|
2:00 p.m. – 4:00 p.m. |
Natcher Conference Center, Building 45 |
NIAID |
IMMUNO-12 |
* FARE Award Winner
Authors
- K.N. Kindrachuk
- T.R. Ramalingam
- M.M. Mentink-Kane
- L. Barron
- K.M. Vannella
- J. Kindrachuk
- S. White
- C. DeClercq
- C. Williams
- C. Hubeau
- A. Cheever
- C.M. Evans
- T.A. Wynn
Abstract
Secreted mucins are large complex glycoproteins that determine the dynamic viscoelastic properties of mucus. MUC5AC is a secreted mucin produced by goblet cells of the airway epithelium and is the predominant mucin in the lungs of individuals with allergic asthma. Upregulation of MUC5AC in allergic airways is largely mediated by the type-2 cytokine IL-13, the cytokine responsible for driving much of the pathology associated with allergic asthma. Here, we show that mice deficient in Muc5ac develop airway eosinophilia or mucus cell metaplasia in three models of type-2-mediated lung inflammation. Mechanistically, we demonstrate that Muc5ac is required for type-2 cytokine signaling via the IL13Rα1 chain of the type II IL-4 receptor and that this effect is cell intrinsic and thus not due to secreted Muc5ac. This work uncovers a novel and essential role for Muc5ac in controlling the pathology of allergic asthma and other Th2-mediated diseases.
